NCT04488341

Brief Summary

PURPOSE: to determine the effect of aerobic exercise training on sex hormones and coagulation factors in postmenopausal elderly women BACKGROUND: Cardiovascular disease (CVD) is the largest cause of death in women, and the risk of developing CVD increases after menopause . Because thrombosis is thought to be a cause of most acute cardiovascular events, abnormalities in endogenous coagulation and fibrinolysis may play an important role in the risk of an acute cardiovascular event. Aging is also associated with adverse changes in both coagulation and fibrinolysis. For instance, postmenopausal women exhibit higher fibrinogen levels and lower levels of endogenous fibrinolysis. Physical activity and physical fitness have consistently been linked to lower CVD rates in women. In fact, an inverse association between physical activity and total mortality, as well as a 50% reduction in risk of myocardial infarction, has been observed in physically active postmenopausal women. In addition to the numerous other benefits provided by regular physical activity, one of the mechanisms mediating the cardioprotective effect may be changes in the hemostatic system, particularly fibrinolysis HYPOTHESES: Aerobic exercises may have no effect on sex hormones and coagulation factors in elderly postmenopausal women RESEARCH QUESTION: Do aerobic exercises effect on sex hormones and coagulation factors in elderly postmenopausal women in response to exercises?

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2020

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 28, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

September 20, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 20, 2022

Completed
Last Updated

August 11, 2021

Status Verified

August 1, 2021

Enrollment Period

1.6 years

First QC Date

July 14, 2020

Last Update Submit

August 9, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • coagulation factors

    change of selected coagulation factors by blood analysis (plasminogen activator inhibitor-1 ,tissue plasminogen activator ,Prothrombin time ,Partial Thromboplastin time ,fibrinogen )

    12 weeks

  • sex hormones

    change of (estradiol ,testosterone. sex hormone binding globin )

    12 weeks

Secondary Outcomes (2)

  • weight

    12 weeks

  • height

    12 weeks

Study Arms (2)

aerobic exercises in addition to diet

OTHER

The study group will receive aerobic exercises in addition to diet recommendations

Other: aerobic exercises in addition to diet recommendationsOther: diet recommendations

diet recommendations

OTHER

control group will receive diet recommendations

Other: diet recommendations

Interventions

aerobic exercises time of session 40-50 min initial 10 min warm up exercises on treadmill in low intensity and active phase 20- 30 min intensity will increase until patient reach to target heart rate then intensity decrease until session will be ended by cooling down phase for 10 min . The volunteers will perform exercises 3 times per week for 12 weeks

aerobic exercises in addition to diet

control group will receive diet recommendations for 12 weeks

aerobic exercises in addition to dietdiet recommendations

Eligibility Criteria

Age60 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • forty Postmenopausal women (60-70 y)
  • Body mass index (BMI) ranged from 35 to 39.9 kg/m2

You may not qualify if:

  • regular medications(e.g., β-blockers, α-blockers, digoxin, diuretics, aspirin, nitrates, Presently using hormone replacement therapy (HRT) and non steroidal anti-inflammatory drugs,
  • smoking;
  • cognitive impairment that will make it difficult to partake in the study
  • presence of malignant disease
  • blood donation within the last 6 months
  • Participation as a subject in any type of study or research during the prior 90 days
  • hypertension,
  • having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and inflammatory bowel disease) and diabetes mellitus or other (unstable) endocrine-related diseases
  • personal history of cardiovascular diseases,
  • Orthopedic problems inhibiting exercises.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical Therapy

Cairo, 11432, Egypt

RECRUITING

MeSH Terms

Conditions

Hemostatic Disorders

Interventions

Exercise

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesHemorrhagic DisordersHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • hany fm elsisi, phd

    physical therapy faculty Cairo university

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hany FM Elsisi, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 14, 2020

First Posted

July 28, 2020

Study Start

September 20, 2020

Primary Completion

May 15, 2022

Study Completion

August 20, 2022

Last Updated

August 11, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will share

all IPD that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
2 years after completion study
Access Criteria
journal publishes the study
More information

Locations